185 related articles for article (PubMed ID: 35768667)
21. Is a specific T classification needed for extrahepatic intraductal papillary neoplasm of the bile duct (IPNB) type 2 associated with invasive carcinoma?
Mitake Y; Onoe S; Igami T; Mizuno T; Yamaguchi J; Sunagawa M; Watanabe N; Kawakatsu S; Shimoyama Y; Ebata T
J Hepatobiliary Pancreat Sci; 2023 Jun; 30(6):745-754. PubMed ID: 36349508
[TBL] [Abstract][Full Text] [Related]
22. Systemic immune-inflammation index as a prognostic marker for distal cholangiocarcinoma.
Terasaki F; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
Surg Today; 2021 Oct; 51(10):1602-1609. PubMed ID: 34142236
[TBL] [Abstract][Full Text] [Related]
23. Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.
Soares KC; Jolissaint JS; McIntyre SM; Seier KP; Gönen M; Sigel C; Nasar N; Cercek A; Harding JJ; Kemeny NE; Connell LC; Koerkamp BG; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Wei AC; Jarnagin WR
Cancer Med; 2023 Jun; 12(11):12272-12284. PubMed ID: 37062071
[TBL] [Abstract][Full Text] [Related]
24. Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium.
Beal EW; Wei L; Ethun CG; Black SM; Dillhoff M; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Pawlik TM; Scoggins C; Martin RC; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR
HPB (Oxford); 2016 Nov; 18(11):950-957. PubMed ID: 27683047
[TBL] [Abstract][Full Text] [Related]
25. Osteosarcopenia is a significant predictor of recurrence and the prognosis after resection for extrahepatic bile duct cancer.
Matsumoto M; Onda S; Igarashi Y; Hamura R; Uwagawa T; Furukawa K; Shirai Y; Gocho T; Haruki K; Ikegami T
Surg Today; 2024 May; 54(5):407-418. PubMed ID: 37700170
[TBL] [Abstract][Full Text] [Related]
26. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
[TBL] [Abstract][Full Text] [Related]
27. It is the lymph node ratio that determines survival and recurrence patterns in resected distal cholangiocarcinoma. A multicenter international study.
Di Martino M; Koh YX; Syn N; Min Chin K; Fernando Burdió ; Sánchez Velázquez P; Manzoni A; Benedetti Cacciaguerra A; Prieto M; Lancellotti F; Malleo G; Marchegiani G; Salvia R; Vennarecci G; Abu Hilal M; Ielpo B
Eur J Surg Oncol; 2022 Jul; 48(7):1576-1584. PubMed ID: 35193776
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of preoperative systemic immune-inflammation index in combined hepatocellular-cholangiocarcinoma.
Zhang F; Hu KS; Lu SX; Li M; Chen RX; Ren ZG; Shi YH; Yin X
Cancer Biomark; 2021; 31(3):211-225. PubMed ID: 33896819
[TBL] [Abstract][Full Text] [Related]
29. Construction and validation of a novel prognostic model for intrahepatic cholangiocarcinoma based on a combined scoring system of systemic immune-inflammation index and albumin-bilirubin: a multicenter study.
Zhang H; Li Q; Huang G; Yang Z; Chen K; Meng B; Yu H
Front Oncol; 2023; 13():1239375. PubMed ID: 37841429
[TBL] [Abstract][Full Text] [Related]
30. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis.
Zhang XF; Xue F; Dong DH; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
Ann Surg; 2021 Dec; 274(6):e1187-e1195. PubMed ID: 31972643
[TBL] [Abstract][Full Text] [Related]
31. Prognostic role of the systemic immune-inflammation index in biliary tract cancers: a meta-analysis of 3,515 patients.
Zhang B; Yao W
World J Surg Oncol; 2022 Sep; 20(1):320. PubMed ID: 36171621
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.
Kelly KJ; Dukleska K; Kuk D; Kingham TP; D'Angelica MI; DeMatteo RP; Allen PJ; Jarnagin WR; Fong Y
Ann Surg Oncol; 2014 Mar; 21(3):979-85. PubMed ID: 24212720
[TBL] [Abstract][Full Text] [Related]
33. Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation.
Dee EC; Freret ME; Horick N; Raldow AC; Goyal L; Zhu AX; Parikh AR; Ryan DP; Clark JW; Allen JN; Ferrone CR; Fernandez-Del Castillo C; Tanabe KK; Drapek LC; Hong TS; Qadan M; Wo JY
Ann Surg Oncol; 2020 Dec; 27(13):5161-5172. PubMed ID: 32740733
[TBL] [Abstract][Full Text] [Related]
34. Systemic Immune-Inflammation Index Is a Prognostic Predictor in Patients with Intrahepatic Cholangiocarcinoma Undergoing Liver Transplantation.
Ren A; Li Z; Cheng P; Zhang X; Deng R; Ma Y
Mediators Inflamm; 2021; 2021():6656996. PubMed ID: 33628115
[TBL] [Abstract][Full Text] [Related]
35. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
[No Abstract] [Full Text] [Related]
36. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy combined with immunotherapy in patients with cholangiocarcinoma after radical resection.
Li XH; Zhou EL; Zhao CY; Cui BK; Dong XY; Du H; Lin XJ
Cancer Med; 2023 Dec; 12(24):21742-21750. PubMed ID: 38059559
[TBL] [Abstract][Full Text] [Related]
39. Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma.
Moazzam Z; Alaimo L; Endo Y; Lima HA; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Cloyd J; Ejaz A; Pawlik TM
J Am Coll Surg; 2023 Apr; 236(4):804-813. PubMed ID: 36728327
[TBL] [Abstract][Full Text] [Related]
40. Inflammation-based prognostic scores in patients with extrahepatic bile duct lesions treated by percutaneous transhepatic biliary stenting combined with
Hu X; Pang Q; Liu H; Qian Z; Jin H; Zhou L; Wang Y; Man Z; Li Z; Yang S
Clin Transl Oncol; 2019 May; 21(5):665-673. PubMed ID: 30368724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
